Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosis
Fields of Study & Subjects
Multiple Sclerosis Research Studies
Complement system in diseases
Neuroinflammation and Neurodegeneration Mechanisms
Publication details
- Journal / source
- Brain Behavior and Immunity
- Volume
- 135
- Pages
- 106526–106526
- Publication date
- 4 March 2026
- Language
- EN